Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Otonomy Inc | NASDAQ:OTIC | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.077 | 0.0757 | 0.0777 | 0 | 01:00:00 |
From Apr 2022 to Apr 2025
A link to the presentation will also become available at the same time through the Events page of the company's website (www.otonomy.com).
About OtonomyOtonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs with a focus on hearing loss and tinnitus. For additional information please visit www.otonomy.com.
Contacts:
Media InquiriesSpectrum ScienceLauren BentonSenior Account Executive212.899.9731lbenton@spectrumscience.com
Investor Inquiries:ICR Westwicke Robert H. UhlManaging Director858.356.5932robert.uhl@westwicke.com
1 Year Otonomy Chart |
1 Month Otonomy Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
